This websiteโs original language is English. For translation, click the globe icon or choose Translate in the menu.
3 matching records found
Hong Kongโs Securities and Futures Commission (SFC) has directed the stock exchange to suspend trading of US-based biotech firm Cloudbreak Pharma pending an investigation into its US$78 million initial public offering (IPO) last year. โThe SFC has serious concerns that Cloudbreakโs initial public offering may have been rigged to create an artificial impression of demand for Cloudbreakโs shares,โ the SFC said in a statement on Thursday. The regulator considered the suspension โnecessary or...
Kazakhstan and Hong Kong could partner to build biotech unicorns โ private start-ups valued at US$1 billion or more โ by linking the Central Asian countryโs strong tech workforce with the cityโs global financial network, a top academic has said. Huck-Hui Ng, dean of the school of medicine at Kazakhstanโs Nazarbayev University, said the nascent biotech sector in the country has already produced several start-ups in areas including artificial intelligence (AI) and digital health, and could build a...